Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.83%) $83.15
Gas
(1.30%) $1.948
Gold
(-0.15%) $2 343.60
Silver
(0.13%) $27.57
Platinum
(0.79%) $929.40
USD/EUR
(-0.30%) $0.932
USD/NOK
(-0.42%) $10.98
USD/GBP
(-0.40%) $0.797
USD/RUB
(0.25%) $92.11

Sanntidsoppdatering for Brii Biosciences Limited [2137.HK]

Børs: HKSE Sektor: Healthcare Industri: Biotechnology
Sist oppdatert29 apr 2024 @ 05:59
25% discount on Stockinvest.us - Use code: Podcast

6.03% HKD 1.230

Live Chart Being Loaded With Signals

Commentary (29 apr 2024 @ 05:59):

Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a; BRII-835, which has completed Phase-2 for patients with chronic HBV infection; and Amubarvimab/romlusevimab combination therapy for the treatment of COVID-19...

Stats
Dagens volum 2.69M
Gjennomsnittsvolum 4.56M
Markedsverdi 897.46M
EPS HKD0 ( 2024-03-25 )
Neste inntjeningsdato ( HKD0 ) 2024-06-19
Last Dividend HKD0 ( N/A )
Next Dividend HKD0 ( N/A )
P/E -4.73
ATR14 HKD0.00900 (0.73%)

Volum Korrelasjon

Lang: 0.02 (neutral)
Kort: 0.72 (moderate)
Signal:(52.909) Neutral

Brii Biosciences Limited Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Brii Biosciences Limited Korrelasjon - Valuta/Råvare

The country flag 0.74
( moderate )
The country flag 0.82
( strong )
The country flag 0.00
( neutral )
The country flag 0.83
( strong )
The country flag 0.00
( neutral )
The country flag -0.85
( strong negative )

Brii Biosciences Limited Økonomi

Annual 2023
Omsetning: HKD617 000
Bruttogevinst: HKD55.89M (9 058.51 %)
EPS: HKD-0.240
FY 2023
Omsetning: HKD617 000
Bruttogevinst: HKD55.89M (9 058.51 %)
EPS: HKD-0.240
FY 2022
Omsetning: HKD51.63M
Bruttogevinst: HKD51.63M (100.00 %)
EPS: HKD-0.630
FY 2021
Omsetning: HKD0.00
Bruttogevinst: HKD0.00 (0.00 %)
EPS: HKD-5.90

Financial Reports:

No articles found.

Brii Biosciences Limited

Brii Biosciences Limited engages in the development of medicines for the treatment of infectious and central nervous system diseases. The company develops BRII-778 and BRII-732, which are in phase I clinical trials for the treatment of HIV patients; BRII-179 and BRII-835, which are in Phase 2 to evaluate the combination of these two HBV mechanisms for Hepatitis B; BRII-179, a recombinant protein-based HBV immunotherapeutic candidate that is in Phase 1b/2a; BRII-835, which has completed Phase-2 for patients with chronic HBV infection; and Amubarvimab/romlusevimab combination therapy for the treatment of COVID-19. It also develops BRII-296 for the treatment of PPD; BRII-297 for treatment of various depressive disorders; BRII-636, BRII-672, and BRII-693 for the treatment of multi-drug resistant/extensive drug resistant (MDR/XDR) gram-negative infections; and BRII-658 for the treatment of MDR/XDR tuberculosis and non-tuberculosis mycobacteria. The company was incorporated in 2017 and is based in Beijing, China.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.